Literature DB >> 30820764

Increased Risk of Hypertension in Young Adults in Southwest China: Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Dan Li1, Xiaofang Zeng1, Yi Huang1, Han Lei1, Ge Li2, Nan Zhang1, Wei Huang3.   

Abstract

PURPOSE OF REVIEW: To examine the impact of the new 2017 ACC/AHA hypertension guideline on the prevalence of hypertension, its constituent ratio, and their associated factors in southwest China. RECENT
FINDINGS: A total of 14,220 permanent residents ≥ 18 years were enrolled in this survey. According to the 2017 ACC/AHA hypertension guideline, the hypertension prevalence was substantially increased (46.9% vs. 24.5%); consistent across different age and gender groups, while the hypertension awareness (23.8% vs. 45.6%); treatment (18.6% vs. 35.5%); control (2.3% vs. 11.2%); and control among treatment (9.6% vs. 24.0%) patients were decreased in southwest of China. In our cohort, 31.1% participants were newly diagnosed as hypertension. Young adults accounted considerable proportion in this newly diagnosed hypertension population. The proportion of young hypertensive individuals substantially increased, whereas those of the older hypertensive subjects decreased. Among the hypertensive subjects aged ≥ 65 years undergoing treatment, 90% of the elderly subjects were not eligible for hypertension control and 32.5% have systolic blood pressure control at 130-149 mmHg, and thus need to intensify antihypertensive treatment according to 2017 ACC/AHA hypertension guideline. Smoking, drinking, body fat percentage, and body mass index were considered the factors associated with hypertension according to the Chinese hypertension guideline but not in the 2017 ACC/AHA hypertension guideline. The adoption of the 2017 ACC/AHA hypertension guideline will substantially increase hypertension prevalence in southwest of China. The new definition of hypertension implies that more young adults will likely suffer from high cardiovascular risks, while additional one third of elder hypertensive subjects will likely need intensified antihypertension treatments.

Entities:  

Keywords:  2017 ACC/AHA hypertension guideline; Chinese hypertension guideline; Control rate; Hypertension; Prevalence

Mesh:

Substances:

Year:  2019        PMID: 30820764     DOI: 10.1007/s11906-019-0926-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  8 in total

1.  Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran.

Authors:  Fatemeh Sadeghi; Bahman Cheraghian; Zahra Mohammadi; Sadaf G Sepanlou; Sahar Masoudi; Zahra Rahimi; Leila Danehchin; Yousef Paridar; Farhad Abolnezhadian; Mohammad Noori; Seyed Ali Mard; Ali Akbar Shayesteh; Hossein Poustchi
Journal:  Popul Health Metr       Date:  2021-05-25

2.  The changes in socioeconomic inequalities and inequities in health services utilization among patients with hypertension in Pearl River Delta of China, 2015 and 2019.

Authors:  Yan Liu; Nan Liu; Mengjiao Cheng; Xin Peng; Junxuan Huang; Jinxiang Ma; Peixi Wang
Journal:  BMC Public Health       Date:  2021-05-12       Impact factor: 3.295

3.  Prevalence, awareness, and associated factors of high blood pressure among female migrant workers in Central South China.

Authors:  Hua Peng; Mei Sun; Xin Hu; Huiwu Han; Jing Su; Emin Peng; James Wiley; Lisa Lommel; Jyu-Lin Chen
Journal:  PeerJ       Date:  2022-05-04       Impact factor: 3.061

4.  Hypertension prevalence alteration in 92 815 nurses based on the new standard by 2017 ACC/AHA hypertension guideline: observational cross-sectional study from China.

Authors:  Bin Zhao; Jing Li; Jie Liu; Yuming Hao; Yanjie Zhen; Di Feng; Menghui Xu; Ximin Chen; Xiulan Yang; Aifang Zuo; Rufu Jia; Ruiqin Zhang; Ailing Fan; Yun Wang; Meijin Yuan; Li Tong; Shuling Chen; Jing Cui; Meizhu Zhao; Wei Cui
Journal:  BMJ Open       Date:  2019-08-30       Impact factor: 2.692

5.  Association between self-reported snoring and hypertension among Chinese Han population aged 30-79 in Chongqing, China.

Authors:  Meng Xiao; Xiaojun Tang; Fan Zhang; Li Zhou; Xiaoqing Bu; Xiang Liu; Xianbin Ding; Zhuozhi Shen; Liling Chen; Yunyun Wu; Wenge Tang; Jingfu Qiu
Journal:  Environ Health Prev Med       Date:  2020-12-03       Impact factor: 3.674

6.  Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study.

Authors:  Sadaf Sepanlou; Farid Najafi; Hossein Poustchi; Mahboubeh Parsaeian; Ali Ahmadi; Mohammadhossein Somi; Farhad Moradpour; Reza Alizadeh-Navaei; Ali Gohari; Bijan Zamani; Ali Esmaeilinadimi; Abbas Rezaianzadeh; Fariborz Mansour-Ghanaei; Ehsan Bahramali; Alireza Ansari-Moghaddam; Behrooz Hamzeh; Elham Zanganeh Yousefabadi; Mohammad Javad Zare Sakhvidi; Iraj Mohebbi; Mohammad Reza Fattahi; Azim Nejatizadeh; Hossein Marioryad; Nazgol Motamed-Gorji; Farzin Roozafzai; Sareh Eghtesad; Zahra Mohammadi; Amaneh Shayanrad; Maryam Sharafkhah; Arash Etemadi; Farin Kamangar; Stephen P Juraschek; Reza Malekzadeh
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

7.  Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017.

Authors:  Mohsen Mirzaei; Masoud Mirzaei; Mojtaba Mirzaei; Behnam Bagheri
Journal:  BMC Cardiovasc Disord       Date:  2020-08-14       Impact factor: 2.298

8.  Does obesity modify the epidemiological association between hyperuricemia and the prevalence of hypertension among Northern Chinese community-dwelling people? A Chinese population-based study.

Authors:  Simiao Tian; Yazhuo Liu; Yang Xu; Ao Feng
Journal:  BMJ Open       Date:  2019-11-21       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.